Abstract

Breast cancer is a frequent malignancy seen in population and accurate staging at diagnosis and early diagnosis of recurrence in the follow-up have a critical importance in order to offer accurate therapy options and improvement of survival. At every step of the course of the disease, anatomic and functional imaging modalities are used together to obtain the most accurate results. Hybrid positron emission tomography/magnetic resonance imaging (PET/MRI) systems provide more reliable information in oncology patients combining metabolic information obtained from PET, which has gained worldwide availability recently, and MRI, which is the best method in soft tissue imaging, by putting the advantages of the both methods together. In this review, the contributions of PET/MRI in breast cancer and its probable disadvantages will be discussed in comparison with conventional imaging methods.